TNFR1 Mediated Apoptosis Is Protective against Mycobacterium avium in Mice
暂无分享,去创建一个
[1] J. Brożek,et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Y. Nakanishi,et al. Critical role of tumor necrosis factor receptor 1 in the pathogenesis of pulmonary emphysema in mice , 2016, International journal of chronic obstructive pulmonary disease.
[3] I. Inoshima,et al. Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease , 2010, Clinical and experimental immunology.
[4] R. Appelberg,et al. Characterization of the Deregulated Immune Activation Occurring at Late Stages of Mycobacterial Infection in TNF-Deficient Mice1 , 2007, The Journal of Immunology.
[5] Robert Horsburgh,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.
[6] K. Kuwano,et al. Doxycycline Attenuated Pulmonary Fibrosis Induced by Bleomycin in Mice , 2006, Antimicrobial Agents and Chemotherapy.
[7] K. Sunagawa,et al. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. , 2005, Cardiovascular research.
[8] K. Kuwano,et al. Retinoic acid fails to reverse emphysema in adult mouse models , 2004, Thorax.
[9] T. Standiford,et al. Increased Mortality and Dysregulated Cytokine Production in Tumor Necrosis Factor Receptor 1-Deficient Mice following Systemic Klebsiella pneumoniae Infection , 2003, Infection and Immunity.
[10] M. Sheikh,et al. Death Receptor Activation Complexes: It Takes Two to Activate TNF Receptor 1 , 2003, Cell cycle.
[11] M. Fujita,et al. Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta. , 2003, American journal of respiratory cell and molecular biology.
[12] Gang Liu,et al. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. , 2003, American journal of respiratory cell and molecular biology.
[13] D. Männel,et al. The TNFTNF Receptor System , 2002 .
[14] T. Lawrence,et al. Possible new role for NF-κB in the resolution of inflammation , 2001, Nature Medicine.
[15] R. Wallace,,et al. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[17] K. Kuwano,et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[18] M. Fujita,et al. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[19] R. Arbeit,et al. A Macrophage Invasion Mechanism for Mycobacteria Implicating the Extracellular Domain of Cd43 , 2000, The Journal of experimental medicine.
[20] Klaus Pfeffer,et al. Lethal Granuloma Disintegration in Mycobacteria-Infected TNFRp55−/− Mice Is Dependent on T Cells and IL-121 , 2000, The Journal of Immunology.
[21] Hardy Kornfeld,et al. Virulent Mycobacterium tuberculosis Strains Evade Apoptosis of Infected Alveolar Macrophages1 , 2000, The Journal of Immunology.
[22] R. Hunter,et al. Apoptosis in Mycobacterium tuberculosis infection in mice exhibiting varied immunopathology , 2000, The Journal of pathology.
[23] J. Peschon,et al. Roles of tumor necrosis factor receptor signaling during murine Escherichia coli pneumonia. , 2000, American journal of respiratory cell and molecular biology.
[24] J. Keane,et al. Macrophage apoptosis in mycobacterial infections , 1999, Journal of leukocyte biology.
[25] A. Niimi,et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[26] K. Pfeffer,et al. Fatal Granuloma Necrosis without Exacerbated Mycobacterial Growth in Tumor Necrosis Factor Receptor p55 Gene-Deficient Mice Intravenously Infected with Mycobacterium avium , 1999, Infection and Immunity.
[27] L. Bermudez,et al. Apoptosis of Mycobacterium avium‐infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases , 1999, Clinical and experimental immunology.
[28] D. O'Brien,et al. Tumor Necrosis Factor Alpha Receptor I Is Important for Survival from Streptococcus pneumoniaeInfections , 1999, Infection and Immunity.
[29] D. O'Brien,et al. Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections. , 1999, Infection and immunity.
[30] K. Kuwano,et al. Endothelial Cell Apoptosis in Lipopolysaccharide–Induced Lung Injury in Mice , 1998, International Archives of Allergy and Immunology.
[31] J. Keane,et al. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. , 1998, Journal of immunology.
[32] R. Arbeit,et al. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. , 1997, Journal of immunology.
[33] I. Orme,et al. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms , 1997, Infection and immunity.
[34] R. Wallace,,et al. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. , 1996, American journal of respiratory and critical care medicine.
[35] David Baltimore,et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.
[36] B. Beutler,et al. How do tumor necrosis factor receptors work? , 1995, Journal of inflammation.
[37] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[38] R. Zinkernagel,et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.
[39] T. Mak,et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.
[40] S. Yoshida,et al. Genetic control of natural resistance in mouse macrophages regulating intracellular Legionella pneumophila multiplication in vitro , 1991, Infection and immunity.
[41] L. Bermudez,et al. Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens , 1990, The Journal of experimental medicine.
[42] L. Bermudez,et al. Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. , 1989, Journal of immunology.
[43] W. Sealy,et al. Long-term results of pulmonary resection for atypical mycobacterial disease. , 1983, The Annals of thoracic surgery.
[44] R. Corpe. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. , 1981, Reviews of infectious diseases.